Reporting here follows heart disease — cardiovascular research, new treatments and procedures, heart failure and heart attack findings, risk factor studies and the guideline updates that translate research into clinical practice. Coverage runs from drug approvals and clinical findings through the caregiving and early-detection research that reaches people outside the patient population.
A meta-analysis of 58 studies links early-onset cancer survival to higher rates of several cardiovascular conditions.
Live Poll
Do you think doctors should routinely monitor heart health in young cancer survivors?
November 8, 2026
Left Bundle-Branch Pacing Beats Right Ventricular PacingThe OptimPacing trial found fewer heart failure events and no pacing-induced cardiomyopathy with the left bundle-branch approach.
November 8, 2026
Early Exercise Rehab Boosts Heart Failure Walking DistanceA meta-analysis of 12 randomized trials links early, structured exercise in hospital to better six-minute walk performance in acute heart failure patients.
November 8, 2026
Semaglutide Improves Heart Filling in Obesity-Linked Heart FailureA substudy of the CAMEO-SEMA trial links the drug to better left atrial and ventricular function in patients with preserved ejection fraction.
November 8, 2026
Smart Alerts Speed Volunteer Cardiac Arrest ResponseA randomized trial in Freiburg, Germany found an algorithm that selects volunteer responders by travel time got help to suspected cardiac arrests before ambulances arrived.
November 6, 2026
Aspirin Shows Inconclusive Results for CKD PatientsA large UK trial found no clear evidence that daily aspirin prevents first heart events in adults with chronic kidney disease.
November 6, 2026
PulseAI Gains FDA Clearance for Arrhythmia AIThe Belfast-developed software analyzes heart rhythm readings captured by smartwatches and other wearable devices.
November 5, 2026
Registry Reports Patency Data for WRAPSODY DeviceReal-world results from the AVF cohort of the WRAP Global Registry were announced alongside presentation at the CiDA conference.
November 5, 2026
Fuwai Hospital Signs Pact With 13 Indonesian HospitalsThe five-year memorandum of understanding covers training, clinical exchanges, and cross-border referral for complex heart cases.
November 4, 2026
Study Tests hERG IC10 for Drug QT RiskResearchers propose a 10% hERG channel inhibition threshold as an alternative to the conventional IC50 approach for assessing drug-induced QT prolongation.
November 4, 2026
Experts Urge Clear Cardiovascular Care PathwaysPanelists at a London summit said advances in cardiovascular diagnostics must translate into defined treatment decisions and follow-up.
The beat runs across clinical trial results for new cardiovascular drugs and devices, guideline revisions from cardiology associations, risk factor research, procedure approval and adoption, cardiac event data and the public health campaigns that follow significant findings. Cardiovascular disease remains the leading cause of death in many countries, giving heart disease coverage a scale and audience reach that few other health subjects match. Guideline changes — on blood pressure targets, cholesterol treatment thresholds or aspirin use — attract broad attention because they affect the clinical care of large patient populations and sometimes reverse previous recommendations. Wearable health technology has expanded the data available on cardiac events and arrhythmia detection, producing a coverage track that connects consumer electronics to cardiology in ways that regulatory bodies are still working to classify.
